NVNO - enVVeno Medical Corporation

12.08
0.380   3.146%

Share volume: 14,480
Last Updated: 04-20-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.03%

PREVIOUS CLOSE
CHG
CHG%
$11.70
0.38
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
33%
Profitability 35%
Dept financing 21%
Liquidity 44%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
5.41%
1 Month
14.94%
3 Months
10.62%
6 Months
1,558.66%
1 Year
399.17%
2 Year
146.03%
Key data
Stock price
$12.08
P/E Ratio 
N/A
DAY RANGE
$11.20 - $12.08
EPS 
-$7.12
52 WEEK RANGE
$0.30 - $12.85
52 WEEK CHANGE
$362.84
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
655.521 K
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-07-2025
BETA 
1.42
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$6,442
AVERAGE 30 VOLUME 
$9,683
Company detail
CEO: Robert A. Berman
Region: US
Website: envveno.com
Employees: 30
IPO year: 2018
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

enVVeno Medical Corporation focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the. treatment of severe deep venous chronic venous insufficiency.

Recent news